607 related articles for article (PubMed ID: 9442070)
1. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA
J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070
[TBL] [Abstract][Full Text] [Related]
2. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
3. The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease.
Hui GK; Wright DW; Vennard OL; Rayner LE; Pang M; Yeo SC; Gor J; Molyneux K; Barratt J; Perkins SJ
Biochem J; 2015 Oct; 471(2):167-85. PubMed ID: 26268558
[TBL] [Abstract][Full Text] [Related]
4. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
5. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
6. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
7. FcαRI binding at the IgA1 C
Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
9. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.
Field MC; Amatayakul-Chantler S; Rademacher TW; Rudd PM; Dwek RA
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):261-75. PubMed ID: 8166649
[TBL] [Abstract][Full Text] [Related]
11. Distinct Fcα receptor
Göritzer K; Turupcu A; Maresch D; Novak J; Altmann F; Oostenbrink C; Obinger C; Strasser R
J Biol Chem; 2019 Sep; 294(38):13995-14008. PubMed ID: 31362986
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
Lardinois OM; Deterding LJ; Hess JJ; Poulton CJ; Henderson CD; Jennette JC; Nachman PH; Falk RJ
PLoS One; 2019; 14(2):e0213215. PubMed ID: 30818380
[TBL] [Abstract][Full Text] [Related]
13. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
14. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.
Carayannopoulos L; Hexham JM; Capra JD
J Exp Med; 1996 Apr; 183(4):1579-86. PubMed ID: 8666916
[TBL] [Abstract][Full Text] [Related]
15. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
17. Effects of limited reduction on disulfide bonds in human IgA1 and IgA1 fragments.
Biewenga J; van Run PE
Mol Immunol; 1992 Mar; 29(3):327-34. PubMed ID: 1557043
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
19. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors.
Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ
J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050
[TBL] [Abstract][Full Text] [Related]
20. Restricted processing of CD16a/Fc γ receptor IIIa
Patel KR; Roberts JT; Subedi GP; Barb AW
J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]